Literature DB >> 9874484

The role of DYT1 in primary torsion dystonia in Europe.

E M Valente1, T T Warner, P R Jarman, D Mathen, N A Fletcher, C D Marsden, K P Bhatia, N W Wood.   

Abstract

Primary torsion dystonia (PTD) is a clinically and genetically heterogeneous movement disorder. DYT1 on chromosome 9q34 was the first PTD gene to be mapped. A 3-bp (GAG) deletion in this gene was reported to account for almost all early limb-onset generalized PTD. No relationship has been found with DYT1 in patients with prominent craniocervical involvement. To elucidate the DYT1-associated phenotype, we analysed the DYT1 mutation in 150 PTD patients, either sporadic or index cases from small PTD families. Twenty-two patients were positive for the GAG deletion in the DYT1 gene. Fifteen of them presented with the typical DYT1 phenotype (early, limb-onset generalized dystonia without spread to craniocervical muscles), four had limb-onset dystonia with spread to craniocervical muscles, two patients had arm-onset segmental dystonia and one had focal right-arm dystonia. One-hundred and twenty-eight patients were negative for the DYT1 mutation. Forty-six of them had segmental dystonia and 59 had focal dystonia. The other 23 patients presented with generalized dystonia, either with craniocervical involvement (13 patients) or without spread to the craniocervical region (typical DYT1 phenotype-10 patients). These data confirm the importance of the GAG deletion in European cases of PTD, and indicate phenotypic and genotypic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874484     DOI: 10.1093/brain/121.12.2335

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

Review 1.  Genetics of movement disorders and ataxia.

Authors:  Paul R Jarman; Nicholas W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

Review 2.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 3.  Diagnosis of dystonic syndromes--a new eight-question approach.

Authors:  Kelly L Bertram; David R Williams
Journal:  Nat Rev Neurol       Date:  2012-03-20       Impact factor: 42.937

4.  Primary torsion dystonia due to the Tor1A GAG deletion in an Irish family.

Authors:  S O'Riordan; D Cockburn; D Barton; T Lynch; M Hutchinson
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

5.  Hurt, tired and queasy: Specific variants in the ATPase domain of the TRAP1 mitochondrial chaperone are associated with common, chronic "functional" symptomatology including pain, fatigue and gastrointestinal dysmotility.

Authors:  Richard G Boles; Holly A Hornung; Alastair E Moody; Thomas B Ortiz; Stacey A Wong; Julie M Eggington; Christine M Stanley; Mu Gao; Hongyi Zhou; Stephen McLaughlin; Amir S Zare; Katherine M Sheldon; Jeffrey Skolnick; Kevin J McKernan
Journal:  Mitochondrion       Date:  2015-05-27       Impact factor: 4.160

Review 6.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 7.  Update on pediatric dystonias: etiology, epidemiology, and management.

Authors:  Emilio Fernández-Alvarez; Nardo Nardocci
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-04-11

8.  Tremulous cervical dystonia is likely to be familial: clinical characteristics of a large cohort.

Authors:  I Rubio-Agusti; I Pareés; M Kojovic; M Stamelou; T A Saifee; G Charlesworth; U M Sheerin; M J Edwards; K P Bhatia
Journal:  Parkinsonism Relat Disord       Date:  2013-03-21       Impact factor: 4.891

9.  The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran.

Authors:  Mohammad Hamid; Mohammad Taghi Akbari; Gholam Ali Shahidi; Zahra Zand
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

10.  High-throughput mutational analysis of TOR1A in primary dystonia.

Authors:  Jianfeng Xiao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Andrew Blitzer; Sat Dev Batish; Zbigniew K Wszolek; Ryan J Uitti; Peter Hedera; David K Simon; Daniel Tarsy; Daniel D Truong; Karen P Frei; Ronald F Pfeiffer; Suzhen Gong; Yu Zhao; Mark S LeDoux
Journal:  BMC Med Genet       Date:  2009-03-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.